Shandong Phoenix Pharmaceuticals, Ltd.
Shandong Phoenix Pharmaceuticals, Ltd., a prominent player in the pharmaceutical industry, is headquartered in Shandong Province, China. Founded in 2001, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, catering to both domestic and international markets. With a strong focus on research and development, Shandong Phoenix Pharmaceuticals offers a diverse range of products, including antibiotics, anti-cancer agents, and cardiovascular medications. Their commitment to innovation and quality has earned them a solid reputation, positioning them favourably within the competitive landscape of the pharmaceutical sector. Notable achievements include various certifications and partnerships that underscore their dedication to excellence and compliance with global standards.
DitchCarbon Score
How does Shandong Phoenix Pharmaceuticals, Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shandong Phoenix Pharmaceuticals, Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shandong Phoenix Pharmaceuticals, Ltd.'s reported carbon emissions
Shandong Phoenix Pharmaceuticals, Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Shandong Phoenix Pharmaceuticals aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for carbon reduction. In summary, without specific emissions data or climate commitments, Shandong Phoenix Pharmaceuticals, Ltd. appears to have limited visibility in terms of its carbon footprint and climate strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong Phoenix Pharmaceuticals, Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
